Scoop has an Ethical Paywall
Work smarter with a Pro licence Learn More

News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC decision on Herceptin supported by WHA


PHARMAC decision on Herceptin supported by WHA

Women’s Health Action supports the decision by PHARMAC and DHBNZ not to fund Herceptin at this time.

Women’s Health Action director, Jo Fitzpatrick says that her organisation has been concerned about the lack of current research data and the high cost of the drug.

‘As a women’s health organisation we find ourselves in a tricky position because it’s our job to give women accurate health information and advocate for women’s health. However, as an evidence-based organisation, we find it difficult to justify funding for Herceptin at this time.

More information: http://www.womens-health.org.nz/papers/papers.htm


Ends

Advertisement - scroll to continue reading

Are you getting our free newsletter?

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.